Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA Accepts for Filing Supplemental Biologics License Application (sBLA) for Xeomin® (incobotulinumt

biospaceMarch 15, 2018

Tag: FDA , sBLA

PharmaSources Customer Service